David Bruce Sable MD

Summary

• David Sable MD is a physician, academic, and investor with a long career in reproductive endocrinology and life sciences. He earned his M.D. from the University of Pennsylvania in 1986, following a B.S. from the Wharton School in 1981. He did his residency in Obstetrics and Gynecology at New York Hospital-Cornell Medical Center, and a fellowship in Reproductive Endocrinology and Infertility at Brigham and Women’s Hospital in Boston. He is board-certified in Obstetrics and Gynecology (1994) and Reproductive Endocrinology (1997), and a past Fellow of both the American College of Obstetricians and Gynecologists and the American College of Surgeons.
  
  Dr. Sable has held academic appointments at Harvard Medical School and Columbia University, where he teaches Entrepreneurship in Biotechnology in the Department of Biological Sciences. He co-founded the Division of Reproductive Endocrinology at Saint Barnabas Medical Center, and embryo diagnostic company Reprogenetics, later acquired by Cooper Surgical. His management positions include healthcare analyst at Deutsche Bank and portfolio manager of the Special Situations Life Sciences Fund and the Special Situations Life Sciences Innovation Fund. He holds advisory and director positions for several biotech companies, including Hamilton Thorne Ltd., TMRW Life Sciences, Celmatix, AutoIVF Inc., Conceivable, and Evvy, and was a member of the board of directors of RESOLVE, which in 2023 awarded him the Barbara Eck Founders Award for lifetime achievement. He is also the recipient of the American Infertility Association’s Family Building Award and RÉSOLVE of New Jersey’s Zenith Award.